Cargando…

The role of carbon-ion radiotherapy in the treatment of adenoid cystic carcinoma of the nasopharynx

BACKGROUND: Nasopharyngeal adenoid cystic carcinoma (NACC) is a distinct subgroup of adenoid cystic carcinoma (ACC) with limited surgical access but predilection of regional and distant metastasis. Although radiotherapy is an integral treatment for patients with NACC, photon-based radiotherapy yield...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jiyi, Hu, Weixu, Gao, Jing, Yang, Jing, Qiu, Xianxin, Huang, Qingting, Kong, Lin, Lu, Jiade J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761180/
https://www.ncbi.nlm.nih.gov/pubmed/36544666
http://dx.doi.org/10.21037/atm-20-1767
_version_ 1784852652910182400
author Hu, Jiyi
Hu, Weixu
Gao, Jing
Yang, Jing
Qiu, Xianxin
Huang, Qingting
Kong, Lin
Lu, Jiade J.
author_facet Hu, Jiyi
Hu, Weixu
Gao, Jing
Yang, Jing
Qiu, Xianxin
Huang, Qingting
Kong, Lin
Lu, Jiade J.
author_sort Hu, Jiyi
collection PubMed
description BACKGROUND: Nasopharyngeal adenoid cystic carcinoma (NACC) is a distinct subgroup of adenoid cystic carcinoma (ACC) with limited surgical access but predilection of regional and distant metastasis. Although radiotherapy is an integral treatment for patients with NACC, photon-based radiotherapy yielded suboptimal local control. Because of its advantages in biology and physics properties, carbon-ion radiotherapy (CIRT) was attempted for the treatment of head and neck ACC; however, the use of CIRT specifically for NACC has not been investigated. METHODS: Patients with NACC that received CIRT alone or a combination of CIRT and proton beam therapy (PBT) at the Shanghai Proton and Heavy Ion Center (SPHIC) between July 2016 and March 2019 were included in the analysis. Patients with newly diagnosed NACC received combined therapy of CIRT (as boost) and PBT, and those with recurrent disease received CIRT alone. Overall survival (OS), local progression-free survival (LPFS), regional progression-free survival (RPFS), and distant metastasis-free survival (DMFS) were calculated by Kaplan-Meier method. RESULTS: A total of 22 patients were included in this analysis. Among those, 18 patients had newly diagnosed NACC (17 with locally advanced disease), and 4 had recurrent NACC including 2 failed previous irradiation. After a median follow-up of 30.9 months, the 2-year OS rate, PFS rate, LPFS rate, RPFS rate and DMFS rate were 100%, 84.8%, 94.4%, 100%, and 84.8%, respectively. Three patients experienced grade 3 mucositis or xerostomia. No late toxicity of grade ≥3 was observed. CONCLUSIONS: CIRT alone or in combination with PBT appeared to be a promising modality for the treatment of NACC and produced satisfactory local disease control and toxicity profile. Distant metastasis remained to be a substantial mode for treatment failure. Further follow-up is necessary to evaluate long-term survivals and late toxicity profile.
format Online
Article
Text
id pubmed-9761180
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-97611802022-12-20 The role of carbon-ion radiotherapy in the treatment of adenoid cystic carcinoma of the nasopharynx Hu, Jiyi Hu, Weixu Gao, Jing Yang, Jing Qiu, Xianxin Huang, Qingting Kong, Lin Lu, Jiade J. Ann Transl Med Original Article BACKGROUND: Nasopharyngeal adenoid cystic carcinoma (NACC) is a distinct subgroup of adenoid cystic carcinoma (ACC) with limited surgical access but predilection of regional and distant metastasis. Although radiotherapy is an integral treatment for patients with NACC, photon-based radiotherapy yielded suboptimal local control. Because of its advantages in biology and physics properties, carbon-ion radiotherapy (CIRT) was attempted for the treatment of head and neck ACC; however, the use of CIRT specifically for NACC has not been investigated. METHODS: Patients with NACC that received CIRT alone or a combination of CIRT and proton beam therapy (PBT) at the Shanghai Proton and Heavy Ion Center (SPHIC) between July 2016 and March 2019 were included in the analysis. Patients with newly diagnosed NACC received combined therapy of CIRT (as boost) and PBT, and those with recurrent disease received CIRT alone. Overall survival (OS), local progression-free survival (LPFS), regional progression-free survival (RPFS), and distant metastasis-free survival (DMFS) were calculated by Kaplan-Meier method. RESULTS: A total of 22 patients were included in this analysis. Among those, 18 patients had newly diagnosed NACC (17 with locally advanced disease), and 4 had recurrent NACC including 2 failed previous irradiation. After a median follow-up of 30.9 months, the 2-year OS rate, PFS rate, LPFS rate, RPFS rate and DMFS rate were 100%, 84.8%, 94.4%, 100%, and 84.8%, respectively. Three patients experienced grade 3 mucositis or xerostomia. No late toxicity of grade ≥3 was observed. CONCLUSIONS: CIRT alone or in combination with PBT appeared to be a promising modality for the treatment of NACC and produced satisfactory local disease control and toxicity profile. Distant metastasis remained to be a substantial mode for treatment failure. Further follow-up is necessary to evaluate long-term survivals and late toxicity profile. AME Publishing Company 2022-11 /pmc/articles/PMC9761180/ /pubmed/36544666 http://dx.doi.org/10.21037/atm-20-1767 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Hu, Jiyi
Hu, Weixu
Gao, Jing
Yang, Jing
Qiu, Xianxin
Huang, Qingting
Kong, Lin
Lu, Jiade J.
The role of carbon-ion radiotherapy in the treatment of adenoid cystic carcinoma of the nasopharynx
title The role of carbon-ion radiotherapy in the treatment of adenoid cystic carcinoma of the nasopharynx
title_full The role of carbon-ion radiotherapy in the treatment of adenoid cystic carcinoma of the nasopharynx
title_fullStr The role of carbon-ion radiotherapy in the treatment of adenoid cystic carcinoma of the nasopharynx
title_full_unstemmed The role of carbon-ion radiotherapy in the treatment of adenoid cystic carcinoma of the nasopharynx
title_short The role of carbon-ion radiotherapy in the treatment of adenoid cystic carcinoma of the nasopharynx
title_sort role of carbon-ion radiotherapy in the treatment of adenoid cystic carcinoma of the nasopharynx
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761180/
https://www.ncbi.nlm.nih.gov/pubmed/36544666
http://dx.doi.org/10.21037/atm-20-1767
work_keys_str_mv AT hujiyi theroleofcarbonionradiotherapyinthetreatmentofadenoidcysticcarcinomaofthenasopharynx
AT huweixu theroleofcarbonionradiotherapyinthetreatmentofadenoidcysticcarcinomaofthenasopharynx
AT gaojing theroleofcarbonionradiotherapyinthetreatmentofadenoidcysticcarcinomaofthenasopharynx
AT yangjing theroleofcarbonionradiotherapyinthetreatmentofadenoidcysticcarcinomaofthenasopharynx
AT qiuxianxin theroleofcarbonionradiotherapyinthetreatmentofadenoidcysticcarcinomaofthenasopharynx
AT huangqingting theroleofcarbonionradiotherapyinthetreatmentofadenoidcysticcarcinomaofthenasopharynx
AT konglin theroleofcarbonionradiotherapyinthetreatmentofadenoidcysticcarcinomaofthenasopharynx
AT lujiadej theroleofcarbonionradiotherapyinthetreatmentofadenoidcysticcarcinomaofthenasopharynx
AT hujiyi roleofcarbonionradiotherapyinthetreatmentofadenoidcysticcarcinomaofthenasopharynx
AT huweixu roleofcarbonionradiotherapyinthetreatmentofadenoidcysticcarcinomaofthenasopharynx
AT gaojing roleofcarbonionradiotherapyinthetreatmentofadenoidcysticcarcinomaofthenasopharynx
AT yangjing roleofcarbonionradiotherapyinthetreatmentofadenoidcysticcarcinomaofthenasopharynx
AT qiuxianxin roleofcarbonionradiotherapyinthetreatmentofadenoidcysticcarcinomaofthenasopharynx
AT huangqingting roleofcarbonionradiotherapyinthetreatmentofadenoidcysticcarcinomaofthenasopharynx
AT konglin roleofcarbonionradiotherapyinthetreatmentofadenoidcysticcarcinomaofthenasopharynx
AT lujiadej roleofcarbonionradiotherapyinthetreatmentofadenoidcysticcarcinomaofthenasopharynx